Sunday, June 25, 2017 10:26:17 PM
I believe the key value prospects in this CC response are based on the following four important items presented in the response:
1. Technology accelerator
2. Multiple medical device manufacturers
3. IP holders
4. Logistics and export/import standards
Any single or combination of items 1 to 3 plus item 4 can bring significant value to a company in general.
We know that something is going on with BLDV, Eltron Research, Israel and MJ that is timely based on the industry dynamics, Isreal's leadership in the industry and the prior updates we have received from BLDV:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132391537
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132085237
These updates and the CC response are supported by the CEO's statement at 9:45 in the Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017 where the CEO describes the amount of efforts they have expended to develop the Israel connection to build a couple of partnerships that will drive significant revenue by the end of the year.
Time will tell how significant the Israeli partnerships will be to BLDV.
Go BLDV!
Buy cautiously and sell reluctantly. All of my posts are In My Opinion only based on the DD I have completed. Please do your own DD and make your own decisions.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM